Published in Drug Week, December 3rd, 2004
The impressive results from a study of more than 3,000 obese people were presented at a medical conference November 9, 2004, capping months of anticipation about the new drug, Acomplia, made by the French pharmaceutical firm Sanofi-Aventis.
Doctors called the research exciting and the company, which funded the study, thinks the drug could have blockbuster potential similar to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2004-12-03)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.